BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Scope & Guideline
Fostering innovation in biochemical and biophysical research.
Introduction
Aims and Scopes
- Biochemical Mechanisms and Pathways:
Research articles that elucidate the biochemical pathways and mechanisms underlying cellular processes, including metabolic pathways, signal transduction, and enzyme activity. - Molecular Biology and Genetics:
Studies focused on molecular genetics, including gene expression, regulation, and the molecular basis of genetic diseases, utilizing techniques such as CRISPR and RNA interference. - Cellular and Tissue Responses:
Investigations into how cellular and tissue responses are modulated by various stimuli, including stress, inflammation, and hypoxia, and their implications for disease. - Drug Discovery and Therapeutics:
Research that explores pharmacological interventions, drug mechanisms, and the development of new therapeutic agents for diseases, particularly cancer and metabolic disorders. - Structural Biology and Biophysics:
Studies utilizing advanced imaging and structural analysis techniques to understand the molecular architecture and dynamics of biological macromolecules. - Microbiology and Immunology:
Research focusing on the interactions between host and pathogens, including the immune response to infections and the role of microbiota in health and disease. - Bioinformatics and Computational Biology:
Utilization of computational methods to analyze biological data, including gene expression profiles, protein interactions, and metabolic pathways.
Trending and Emerging
- Ferroptosis and Cell Death Mechanisms:
An increasing number of studies are focusing on ferroptosis as a regulated form of cell death, particularly in cancer research, highlighting its implications in therapeutic resistance. - Microbiome and Metabolomics:
Research exploring the role of the microbiome in health and disease is gaining prominence, particularly in relation to metabolic disorders and immune responses. - CRISPR and Genome Editing Technologies:
The application of CRISPR and other genome editing technologies is trending, with numerous papers discussing their potential for therapeutic interventions and functional genomics. - Nanotechnology in Drug Delivery:
Emerging studies are focusing on the use of nanotechnology for targeted drug delivery systems, enhancing the efficacy and specificity of treatments for various diseases. - Bioinformatics and Systems Biology:
The integration of bioinformatics approaches to analyze complex biological data is increasingly popular, particularly in understanding disease mechanisms and personalizing medicine. - Vascular Biology and Regenerative Medicine:
Research in vascular biology, particularly in relation to regenerative medicine and tissue engineering, is trending, focusing on novel therapeutic strategies for vascular diseases. - Immunotherapy and Cancer Treatment:
The exploration of novel immunotherapeutic strategies, including the use of immune checkpoint inhibitors and CAR-T cell therapies, is a rapidly growing area of research.
Declining or Waning
- Traditional Pharmacology:
Research focusing solely on traditional pharmacological approaches without integration of modern techniques such as molecular biology or genetic engineering is declining. - Basic Biochemical Assays:
Studies that rely on basic biochemical assays without novel insights or applications are becoming less frequent as the field advances towards more complex and integrated approaches. - Single-Cell Studies without Context:
Publications that focus on single-cell studies but lack contextual understanding of tissue microenvironments or systemic interactions are seeing reduced interest. - In vitro Models with Limited Relevance:
Research utilizing in vitro models that do not adequately mimic in vivo conditions are less favored as the demand for more relevant models increases.
Similar Journals
Journal of Biochemistry
Elevating the discourse in biochemistry and molecular biology.Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.
Frontiers in Bioscience-Landmark
Shaping the Future of Bioscience ScholarshipFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
CELLULAR SIGNALLING
Pioneering Research in Cellular SignallingCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
Elevating Research in Receptor DynamicsJOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.
Cell Communication and Signaling
Exploring the Nuances of Molecular SignalingCell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.
FEBS Open Bio
Bridging gaps in knowledge with open-access scholarship.FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.
MOLECULAR AND CELLULAR BIOLOGY
Driving Innovation in Molecular and Cellular ScienceMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
BIOCHEMICAL JOURNAL
Empowering Researchers with Cutting-Edge InsightsBIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.
MOLECULES AND CELLS
Driving Progress in Cellular and Molecular MedicineMOLECULES AND CELLS is a distinguished peer-reviewed journal published by the Korean Society for Molecular and Cellular Biology, dedicated to advancing the fields of Cell Biology, Molecular Biology, and Medicine. With a solid citation record and a robust reputation in its respective categories, the journal has achieved a ranking of Q2 in Cell Biology and Q1 in Miscellaneous Medicine as of 2023, demonstrating its impact and relevance to ongoing research in these vital disciplines. Although currently not open access, MOLECULES AND CELLS strives to provide a platform for innovative studies from diverse areas within molecular and cellular research, fostering collaboration among scientists worldwide. Established in 1996 and continuing to publish leading-edge research until 2024, this journal is essential for researchers, professionals, and students seeking to engage with the latest developments and insights in the life sciences.
FEBS Journal
Where Innovation Meets Molecular InsightsFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.